(Q36944240)

17 August 2017

1 reference

title

Ganoderma lucidum and its pharmaceutically active compounds (English)

1 reference

17 August 2017

Ganoderma lucidum

1 reference

Bojana Boh

1

1 reference

17 August 2017

Marin Berovic

series ordinal

2

1 reference

17 August 2017

Jingsong Zhang

series ordinal

3

1 reference

17 August 2017

Lin Zhi-Bin

series ordinal

4

1 reference

17 August 2017

1 January 2007

1 reference

Biotechnology Annual Review

17 August 2017

1 reference

17 August 2017

13

1 reference

17 August 2017

265-301

1 reference

Anti-allergic constituents in the culture medium of Ganoderma lucidum. (I). Inhibitory effect of oleic acid on histamine release.

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Immunomodulator, LZ-8, prevents antibody production in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Antitumor activity of Sarcodon aspratus (Berk.) S. Ito and Ganoderma lucidum (Fr.) Karst

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Inhibition of cytopathic effect of human immunodeficiency virus-1 by water-soluble extract ofGanoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Submerged cultivation of Ganoderma lucidum biomass and immunostimulatory effects of fungal polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Reishi,Ganoderma lucidumandGanoderma tsugae: Bioactive substances and medicinal effects

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Reusing soy residue for the solid-state fermentation of Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Bistage control of pH for improving exopolysaccharide production from mycelia of Ganoderma lucidum in an air-lift fermentor.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Effect of initial pH on production of ganoderic acid and polysaccharide by submerged fermentation of Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Submerged fermentation of higher fungus Ganoderma lucidum for production of valuable bioactive metabolites—ganoderic acid and polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Significance of inoculation density control in production of polysaccharide and ganoderic acid by submerged culture of Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Fed-batch fermentation of Ganoderma lucidum for hyperproduction of polysaccharide and ganoderic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Role of oxygen supply in submerged fermentation of Ganoderma lucidum for production of Ganoderma polysaccharide and ganoderic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Ganoderic acids T, S and R, new triterpenoids from the cultured mycelia of Ganoderma lucidum.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Constituents of the fungus Ganoderma lucidum (Fr.) Karst. I Structures of ganoderic acids C2, E, I, and K, lucidenic acid F and related compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Triterpenoids from the fungus Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Bitter triterpenoids from the fungus Ganoderma applanatum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Seven New Triterpenes from Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Triterpenes from Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Two New Triterpenes of the Fungus Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Applanoxidic acids A, B, C and D, biologically active tetracyclic triterpenes from Ganoderma applanatum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Lanostanoid triterpenes from Ganoderma applanatum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Les acides ganoderiques tàz : triterpenes cytotoxiques de Ganoderma lucidum (Polyporacée)

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on HeLa cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Anti-androgenic activities of the triterpenoids fraction of Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR)

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

The aggregation of human platelet induced by ganodermic acid S.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

The inhibition of human platelet function by ganodermic acids

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Predominant inhibition of ganodermic acid S on the thromboxane A2-dependent pathway in human platelets response to collagen

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Potentiation of ganodermic acid S on prostaglandin E(1)-induced cyclic AMP elevation in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Anticomplement activity of terpenoids from the spores of Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Ganoderma - a therapeutic fungal biofactory.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Antitumor Polysaccharides from Some Polyporaceae, Ganoderma applanatum (PERS.) PAT and Phellinus linteus (BERK. et CURT) AOSHIMA

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Immune receptors for polysaccharides from Ganoderma lucidum.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Polysaccharides of Ganoderma lucidum alter cell immunophenotypic expression and enhance CD56+ NK-cell cytotoxicity in cord blood

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Structural features of immunologically active polysaccharides from Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Activation of B lymphocytes by GLIS, a bioactive proteoglycan from Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Effects of Ganoderma lucidum polysaccharides on proliferation and cytotoxicity of cytokine-induced killer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Studies on the immuno-modulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi)

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Anti-angiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Mushroom-derived preparations in the prevention of H2O2-induced oxidative damage to cellular DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo[a]pyrene.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Possible mode of action of antiherpetic activities of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

A distinctive ribonuclease from fresh fruiting bodies of the medicinal mushroom Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom Ganoderma lucidum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Mushroom nutriceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Regression of prostate cancer following administration of Genistein Combined Polysaccharide (GCP), a nutritional supplement: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

Ganoderma lucidum Mycelium and Spore Extracts as Natural Adjuvants for Immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2807%2913010-6

7 January 2021

10.1016/S1387-2656(07)13010-6

Identifiers

DOI

1 reference

17 August 2017

1 reference